Tenaris S.A. (TS)
| Market Cap | 29.75B +66.5% |
| Revenue (ttm) | 12.04B +2.3% |
| Net Income | 1.91B -4.5% |
| EPS | 3.73 +1.6% |
| Shares Out | 1.01B |
| PE Ratio | 15.72 |
| Forward PE | 14.66 |
| Dividend | $2.38 (4.05%) |
| Ex-Dividend Date | Nov 24, 2026 |
| Volume | 153,415 |
| Open | 58.55 |
| Previous Close | 57.25 |
| Day's Range | 58.30 - 58.78 |
| 52-Week Range | 34.15 - 64.60 |
| Beta | 0.48 |
| Analysts | Buy |
| Price Target | 64.96 (+10.71%) |
| Earnings Date | Nov 4, 2026 |
About TS
Tenaris S.A., together with its subsidiaries, manufactures and supplies steel pipe products and related services for the energy industry and other industrial applications in North America, South America, Europe, the Middle East and Africa, and the Asia Pacific. It provides steel casings to sustain the walls of oil and gas wells during and after drilling; steel tubing for conducting crude oil and natural gas to the surface after drilling has been completed; steel line pipes to transport crude oil and natural gas from wells to refineries, storage... [Read more]
Financial Performance
In 2025, Tenaris's revenue was $11.98 billion, a decrease of -4.33% compared to the previous year's $12.52 billion. Earnings were $1.93 billion, a decrease of -5.09%.
Financial StatementsAnalyst Summary
According to 12 analysts, the average rating for TS stock is "Buy." The 12-month stock price target is $64.96, which is an increase of 10.71% from the latest price.
News
Tenaris price target raised to $62 from $60 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Tenaris (TS) to $62 from $60 and keeps an Equal Weight rating on the shares. Energy services lagged in Q3, notes the…
Tenaris price target raised to $71 from $66 at BofA
BofA raised the firm’s price target on Tenaris (TS) to $71 from $66 and keeps a Buy rating on the shares. On account of rising U.S. pricing and offshore volumes,…
Tenaris price target lowered to $60 from $65 at Morgan Stanley
Morgan Stanley analyst Joe Laetsch lowered the firm’s price target on Tenaris (TS) to $60 from $65 and keeps an Equal Weight rating on the shares.
Tenaris price target lowered to $80 from $82 at Barclays
Barclays analyst J. David Anderson lowered the firm’s price target on Tenaris (TS) to $80 from $82 and keeps an Overweight rating on the shares. With Middle East disruptions continuing,…
Tenaris Q2 Earnings Call Highlights
Tenaris NYSE: TS reported second-quarter sales of $3 billion, down 4% from both a year earlier and the prior quarter, as shipping disruptions in the Middle East delayed deliveries to customers in Iraq...
Tenaris price target raised to $68 from $67 at TD Cowen
TD Cowen raised the firm’s price target on Tenaris (TS) to $68 from $67 and keeps a Buy rating on the shares. The firm updated its model following Q2 results.
Tenaris Earnings Call Transcript: Q2 2026
Second quarter sales and earnings declined due to Middle East disruptions and higher costs, but investments in the Americas and a strong offshore backlog support a positive outlook for Q4. The board doubled the interim dividend, reflecting strong cash generation and balance sheet.
Tenaris Earnings release: Q2 2026
Tenaris released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
Tenaris Quarterly report: Q2 2026
Tenaris has published its Q2 2026 quarterly earnings report on August 6, 2026.
Tenaris reports Q2 EPS 95c, consensus 82c
Reports Q2 revenue $2.97B, consensus $2.94B. The company stated, “In the second half, we expect our sales and EBITDA to remain in line with the first half, despite sales continuing…
Tenaris Announces 2026 Second Quarter Results
The financial and operational information contained in this press release is based on unaudited consolidated condensed interim financial statements presented in U.S. dollars and prepared in accordance...
NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome
Toronto, Ontario – TheNewswire - July 15, 2026 – NeuroThera Labs Inc. (TSXV: NTLX) (the " Company " or " NeuroThera "), a clinical-stage biotech company and a majority-owned subsidiary of SciSparc Ltd...
Tenaris upgraded to Equal Weight from Underweight at Morgan Stanley
Morgan Stanley upgraded Tenaris (TS) to Equal Weight from Underweight with a price target of $65, up from $53. The firm says improving oil country tubular goods industry fundamentals amid…
Tenaris inaugurates new service center in Suriname to support TotalEnergies's GranMorgu offshore project
PARAMARIBO, Suriname, June 30, 2026 (GLOBE NEWSWIRE) -- Tenaris announced today that operations have started at its new service center in Suriname, built to support the GranMorgu project, the country'...
Tenaris announces $306 million CAD investment to strengthen its Sault Ste. Marie industrial centre, backed by federal and provincial governments
Tenaris announces $306M CAD investment in Sault Ste. Marie facility with federal and provincial governments, strengthening Canadian steel pipe production.
Tenaris price target raised to $60 from $56 at Piper Sandler
Piper Sandler raised the firm’s price target on Tenaris (TS) to $60 from $56 and keeps a Neutral rating on the shares. Looking back on Q1 earnings season, the firm…
Tenaris price target raised to $53 from $50 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Tenaris (TS) to $53 from $50 and keeps an Underweight rating on the shares. The firm adjusted estimates following earnings reports from…
Shareholders approve all resolutions on the agendas of Tenaris's Annual General Meeting and Extraordinary General Meeting of Shareholders
LUXEMBOURG, May 12, 2026 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) announced that its annual general meeting of shareholders and extraordinary general meeting of shareh...
Tenaris to acquire Artrom Steel Tubes plant in Romania
Tenaris (TS) S.A. announced that it has entered into a definitive agreement to acquire from GLGH Steel, a U.S.-based company, 100% of the share capital of Artrom Steel Tubes S.A.,…
Tenaris to Acquire Artrom Steel Tubes S.A. seamless pipe manufacturing plant in Romania
LUXEMBOURG, May 08, 2026 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE and Mexico: TS; EXM Italy: TEN) announced today that it has entered into a definitive agreement to acquire from GLGH Steel, LLC, a U.S.-...
Tenaris price target raised to $82 from $78 at Barclays
Barclays analyst J. David Anderson raised the firm’s price target on Tenaris (TS) to $82 from $78 and keeps an Overweight rating on the shares.
Tenaris price target raised to $78 from $72 at Barclays
Barclays raised the firm’s price target on Tenaris (TS) to $78 from $72 and keeps an Overweight rating on the shares. The firm adjusted ratings and price targets in the…
Tenaris Earnings Call Transcript: Q1 2026
First quarter sales and EBITDA grew year-over-year despite Middle East disruptions, with strong cash flow and a robust net cash position. Q2 faces revenue and margin pressure from regional conflict, but recovery is expected in the second half, supported by North American and offshore growth.
Tenaris Earnings release: Q1 2026
Tenaris released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
Tenaris Quarterly report: Q1 2026
Tenaris has published its Q1 2026 quarterly earnings report on May 7, 2026.